Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers

Kidney International

Volumn 67, Issue 2, 2005, Pages 750-759

  Galli, Francesco ^a   Benedetti, Serena ^b   Floridi, Ardesio ^b   Canestrari, Franco ^b   Piroddi, Marta ^b   Buoncristiani, Emanuela ^b   Buoncristiani, Umberto ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

AGEs; CRP; Cytokines; Glycoxylation; Hemodialysis; Inflammation; Protein oxidation; Protein leaking dialyzers; Uremia; Uremic toxins

Indexed keywords

C REACTIVE PROTEIN; CARBONYL DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOSIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLYCOSIDATION; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LEAKING DIALYZER; UREMIA;

EID: 12344332476     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67138.x     Document Type: Article

References (35)

1. VANHOLDER R, DE SMET R, LAMEIRE N: Protein-bound uremic solutes: The forgotten toxins. Kidney Int 59(Suppl 78):S266-S270, 2001
2. LESAFFER G, DE SMET R, LAMEIRE N, et al: Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 15:50-57, 2000
3. KAYSEN GA, KUMAR V: Inflammation in ESRD: Causes and potential consequences. J Ren Nutr 3:158-160, 2003
4. STENVINKEL P, ALVESTRAND A: Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial 15:329-337, 2002
5. WITKO-SARSAT V, FRIEDLANDER M, NOUYEN KHOA T, et al: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524-2532, 1998
6. DESCAMPS-LATSCHA B, WITKO-SARSAT V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int 59(Suppl 78):S108-S113, 2001
7. SCHWEDLER S, SCHINZEL R, VAITH P, WANNER C: Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship? Kidney Int 59(Suppl 78):S32-S326, 2001
8. MIYATA T, UEDA Y, SHINZATO T, et al: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
9. MIYATA T, KUROKAWA K, VAN YPERSELE DE STRIHOU C: Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11:1744-52, 2000
10. THORNALLEY PJ: Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44:1013-1023, 1998
11. MIYAZAKI A, NAKAYAMA H, HORIUCHI S: Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 12:258-262, 2002
12. OHGAMI N, NAGAI R, IKEMOTO M, et al: Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 276:3195-3202, 2001
13. KISLINGER T, FU C, HUBER B, et al: N(epsilon)-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749, 1999
14. HORIUCHI S, SAKAMOTO Y, SAKAI M: Scavenger receptors for oxidized and glycated proteins. Amino Acids 25:283-92, 2003
15. MORENA MD, GUO D, BALAKRISHNAN VS, et al: Effect of a novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int 63:1150-1154, 2003
16. KAWANISHI H. Selection of treatment condition and membranes in acute blood purification therapy. Critical Care Treatment 12(Suppl):s7-s9, 2000
17. BONOMINI M, FIEDERLING B, BUCCIARELLI T, et al: A new polymethyl-methacrylate membrane for hemodialysis. Int J Artif Organs 19:232-239, 1996
18. MANN H, MELZER H, AL-BASHIR A, et al: Testing protein permeability of dialysis membranes using SDS-PAGE. Int J Artif Organs 25:441-6, 2002
19. BUONCRISTIANI U, GALLI F, BENEDETTI S, et al: Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes. Contrib Nephrol 125:133-158, 1999
20. NIWA T, ASADA H, TSUTSUI S, MIYAZAKI T: Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol 15:463-467, 1995
21. GALLI F, BENINATI S, BENEDETTI S, et al: Polymeric protein-polyamine conjugates: A new class of uremic toxins affecting erythropoiesis. Kidney Int 59:73-76, 2001
22. GALLI F, GHIBELLI L, BUONCRISTIANI U, et al: Mononuclear leukocytes apoptosis in hemodialysis patients: The role of cell thiols and vitamin E. Nephrol Dial Transplant 18:1592-600, 2003
23. VAN TELLINOEN A, GROOTEMAN MP, BARTELS PC, et al: Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 59:342-347, 2001
24. GALLI F, BENEDETTI S, BUONCRISTIANI U, et al: The effect of PMMA-based "protein-leaking" dialysers on total plasma homocysteine levels. Kidney Int 64:748-755, 2003
25. BOSTOM AG, LATHROP L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
26. FLORIDI A, ANTOLINI F, GALLI F, et al: Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant 17:871-878, 2002
27. FLORIDI A, TRIZZA V, PAOLOTTI P, LUCARELLI C: Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography. J Chromatogr A 846:65-71, 1999
28. LEVINE RL, GARLAND D, OLIVER CN, et al: Determination of carbonyl contenent in oxidatively modified proteins. Methods Enzymol 186:464-478, 1990
29. CLOOS PAC, CHRISTGAU S: Non-enzymatic covalent modifications of proteins: Mechanisms, physiological consequences and clinical applications. Matrix Biology 21:39-52, 2002
30. WINCHESTER JF, KELLUM JA, RONCO C, et al: Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif 21:79-84, 2003
31. PANICHI V, MIOLIORI M, DE PIETRO S, et al: Plasma C-reactive protein in haemodialysis. Blood Purif 17:142-148, 1999
32. LIBETTA C, ZUCCHI M, GORI E, et al: Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int 65:1473-1481, 2004
33. PARKIN J, COHEN B: An overview of the immune system. Lancet 357:1777-1789, 2001
34. GUARNIERI G, ANTONIONE R, BIOLO G: Mechanisms of malnutrition in uremia. J Ren Nutr 13:153-157, 2003
35. QURESHI AR, ALVESTRAND A, DIVINO-FILHO JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13(Suppl 1):S28-36, 2002